Treatment of Migraine Headaches
The most effective approach for migraine treatment is a stepped care strategy, starting with NSAIDs for mild to moderate attacks and progressing to triptans or combination therapy for moderate to severe attacks. 1
Acute Treatment Options
First-Line Treatments
- For mild to moderate migraine attacks, use NSAIDs such as ibuprofen 400-800mg, naproxen sodium 275-550mg, or aspirin 650-1000mg 1, 2
- Acetaminophen has less efficacy than NSAIDs and should only be used in patients who cannot tolerate NSAIDs 1
- Combination analgesics containing caffeine can be effective for mild attacks 1, 2
- For moderate to severe attacks, triptans are recommended as first-line therapy 1, 2
- Triptans are most effective when taken early in an attack while headache is still mild 1
- If one triptan is ineffective, others might still provide relief 1, 3
- Combining a triptan with an NSAID improves efficacy 1, 2
Second-Line Treatments
- CGRP antagonists (gepants) such as rimegepant, ubrogepant, or zavegepant for patients who don't respond to or cannot tolerate triptans plus NSAIDs 1, 2
- Dihydroergotamine (DHE) is an alternative when first-line treatments fail 2
- Antiemetics like metoclopramide or prochlorperazine are recommended, particularly when migraine is accompanied by nausea/vomiting 1, 2
Treatment Considerations
- For patients with severe nausea/vomiting, use non-oral routes of administration such as nasal sprays or injections 1, 2
- Subcutaneous sumatriptan injection can be useful for patients who rapidly reach peak headache intensity or cannot take oral medications due to vomiting 2, 4
- Avoid opioids and butalbital-containing medications due to risk of dependency, rebound headaches, and loss of efficacy 1, 2
- Limit acute medication use to prevent medication overuse headache (≤15 days/month for NSAIDs, ≤10 days/month for triptans) 1, 3
Preventive Treatment
When to Consider Prevention
- Consider preventive therapy for patients with two or more attacks per month producing disability lasting 3+ days per month 1
- Preventive treatment is also indicated for patients with contraindication to or failure of acute treatments 1
- Patients using acute medication more than twice per week should be considered for preventive therapy 1, 5
- Preventive treatment is appropriate for patients with uncommon migraine conditions (hemiplegic migraine, migraine with prolonged aura) 1
Preventive Medication Options
- Beta-blockers, amitriptyline, and divalproex sodium have documented high efficacy with mild to moderate adverse events 5
- Topiramate is an effective option but requires discussion of teratogenic effects with patients of childbearing potential 6
- If recommended treatments are not tolerated or result in inadequate response, consider an ACE inhibitor (lisinopril), an ARB (candesartan or telmisartan), or an SSRI (fluoxetine) 6
- Start preventive medications at a low dose and gradually increase until desired outcomes are achieved 6
Lifestyle Modifications
- Address predisposing factors such as poor sleep quality, poor physical fitness, or stress 1
- Maintain regular meals, stay well hydrated, and ensure sufficient sleep 1
- Engage in regular physical activity, preferably moderate to intense aerobic exercise 1
- Manage stress with relaxation techniques or mindfulness practices 1
Special Considerations
Medication Overuse Headache
- Overuse of acute migraine drugs (e.g., ergotamine, triptans, opioids, or a combination of drugs for 10 or more days per month) may lead to exacerbation of headache 3
- Detoxification of patients, including withdrawal of the overused drugs, may be necessary 3
Cardiovascular Risk
- Triptans should not be given to patients with ischemic or vasospastic coronary artery disease 3
- Patients with multiple cardiovascular risk factors should have a cardiovascular evaluation prior to receiving triptans 3
- For patients with cardiovascular contraindications, gepants and ditans do not have vascular contraindications 7
Monitoring Treatment
- The use of a headache diary may help to determine treatment efficacy, identify analgesic overuse, and follow up on migraine progression 6
- Switch preventive treatment if an adequate response is not achieved during a reasonable trial period (generally 2 to 3 months), or earlier if an adverse effect occurs 6